The rise of AI/ML-enabled diagnostics: Are payers catching up?
Published on March 17, 2025
.t-box { background-color: #e1eff5; padding: 1rem; }
Artificial intelligence (AI) and machine learning (ML) are increasingly gaining a foothold in the medical device landscape. Their transformative potential is particularly evident in medical diagnostics, where AI models and algorithms leverage clinical data to identify and diagnose diseases with greater accuracy.
But as AI-driven diagnostics rapidly evolve, are payers keeping pace? Can reimbursement models adapt quickly enough to support widespread adoption?
A/ML in diagnostics
AI/ML-enabled diagnostic solutions offer significant opportunities to enhance diagnostic accuracy and detect early signs of disease onset (e.g., cancer, stroke or cardiovascular diseases), enabling timely intervention. Other potential applications include prognosis of disease progression, prediction of treatment response for personalized medicine, and risk…